Get started
RocketTickers

GBT Announces Positive 24-week Results from Phase 3 HOPE Study

Long
RocketTickers  
NASDAQ:GBT   None
Beyond Technical Analysis
1
0
beyondta
GBT: Global Blood Therapeutics, Inc.
2018-12-03 10:00:00
GBT Announces Positive 24-week Results from Phase 3 HOPE Study Demonstrating Clinically and Statistically Significant Improvements in Hemoglobin and Clinical Measures of Hemolysis and a Favorable Safety Profile
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.